Acidic mammalian
chitinase (AMCase) and chitotriosidase-1 (CHIT1)
are two enzymatically active proteins produced by mammals capable
of cleaving the glycosidic bond in chitin. Based on the clinical findings
and animal model studies, involvement of chitinases has been suggested
in several respiratory system diseases including asthma, COPD, and
idiopathic pulmonary fibrosis. Exploration of structure–activity
relationships within the series of 1-(3-amino-1H-1,2,4-triazol-5-yl)-piperidin-4-amines,
which was earlier identified as a scaffold of potent AMCase inhibitors,
led us to discover highly active dual (i.e., AMCase and CHIT1) inhibitors
with very good pharmacokinetic properties. Among them, compound 30 was shown to reduce the total number of cells in bronchoalveolar
lavage fluid of mice challenged with house dust mite extract after
oral administration (50 mg/kg, qd). In addition, affinity toward the
hERG potassium channel of compound 30 was significantly
reduced when compared to the earlier reported chitinase inhibitors.
Chitotriosidase (CHIT1) and acidic mammalian chitinase (AMCase) are the enzymatically active chitinases that have been implicated in the pathology of chronic lung diseases such as asthma and interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and sarcoidosis. The clinical and preclinical data suggest that pharmacological inhibition of CHIT1 might represent a novel therapeutic approach in IPF. Structural modification of an advanced lead molecule 3 led to the identification of compound 9 (OATD-01), a highly active CHIT1 inhibitor with both an excellent PK profile in multiple species and selectivity against a panel of other off-targets. OATD-01 given orally once daily in a range of doses between 30 and 100 mg/kg showed significant antifibrotic efficacy in an animal model of bleomycin-induced pulmonary fibrosis. OATD-01 is the first-in-class CHIT1 inhibitor, currently completed phase 1b of clinical trials, to be a potential treatment for IPF.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.